QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Bellerophon Therapeutics (BLPH) Insider Trading & Ownership

$0.05
0.00 (0.00%)
(As of 02/26/2024 ET)

Bellerophon Therapeutics (NASDAQ:BLPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$5.61 M
Get BLPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bellerophon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BLPH Insider Buying and Selling by Quarter


Bellerophon Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/13/2023Puissance Capital Management LMajor ShareholderSell1,076,841$0.10$107,684.10  
6/7/2023Life Science Opportu PuissanceMajor ShareholderSell134,421$0.83$111,569.43  
5/18/2023Bobae KimVPSell9,455$10.00$94,550.00  
5/18/2023Life Science Opportu PuissanceMajor ShareholderSell560,000$9.46$5,297,600.00  
(Data available from 1/1/2013 forward)












BLPH Insider Trading Activity - Frequently Asked Questions

Who is on Bellerophon Therapeutics's Insider Roster?

The list of insiders at Bellerophon Therapeutics includes Bobae Kim, Life Science Opportu Puissance, New Mountain Investments Ii, L, and Puissance Capital Management L. Learn more on insiders at BLPH.

What percentage of Bellerophon Therapeutics stock is owned by insiders?

5.20% of Bellerophon Therapeutics stock is owned by insiders. Learn more on BLPH's insider holdings.

Which Bellerophon Therapeutics insiders have been selling company stock?

The following insiders have sold BLPH shares in the last 24 months: Bobae Kim ($94,550.00), Life Science Opportu Puissance ($5,409,169.43), and Puissance Capital Management L ($107,684.10).

How much insider selling is happening at Bellerophon Therapeutics?

Insiders have sold a total of 1,780,717 Bellerophon Therapeutics shares in the last 24 months for a total of $5,611,403.53 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:BLPH) was last updated on 2/26/2024 by MarketBeat.com Staff